156 related articles for article (PubMed ID: 19967153)
21. Role of platelets in hypercholesterolemia-induced leukocyte recruitment and arteriolar dysfunction.
Stokes KY; Calahan L; Russell JM; Gurwara S; Granger DN
Microcirculation; 2006; 13(5):377-88. PubMed ID: 16815823
[TBL] [Abstract][Full Text] [Related]
22. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium.
Cao D; Mizukami IF; Garni-Wagner BA; Kindzelskii AL; Todd RF; Boxer LA; Petty HR
J Immunol; 1995 Feb; 154(4):1817-29. PubMed ID: 7836767
[TBL] [Abstract][Full Text] [Related]
23. Binding of urokinase plasminogen activator to gp130 via a putative urokinase-binding consensus sequence.
Liang OD; Chavakis T; Linder M; Bdeir K; Kuo A; Preissner KT
Biol Chem; 2003 Feb; 384(2):229-36. PubMed ID: 12675515
[TBL] [Abstract][Full Text] [Related]
24. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
25. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets.
Palabrica T; Lobb R; Furie BC; Aronovitz M; Benjamin C; Hsu YM; Sajer SA; Furie B
Nature; 1992 Oct; 359(6398):848-51. PubMed ID: 1279433
[TBL] [Abstract][Full Text] [Related]
26. [Expression of urokinase-type plasminogen activator and its receptor in plasma of patients with cerebral infarction].
Song SJ; Hu JB; Wang HX; Wen SQ; Ding MP; Huang JZ
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1583-5. PubMed ID: 14642114
[TBL] [Abstract][Full Text] [Related]
27. Urokinase-type plasminogen activator receptor (uPAR) augments brain damage in a murine model of ischemic stroke.
Nagai N; Okada K; Kawao N; Ishida C; Ueshima S; Collen D; Matsuo O
Neurosci Lett; 2008 Feb; 432(1):46-9. PubMed ID: 18164548
[TBL] [Abstract][Full Text] [Related]
28. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
Fox SB; Taylor M; Grøndahl-Hansen J; Kakolyris S; Gatter KC; Harris AL
J Pathol; 2001 Sep; 195(2):236-43. PubMed ID: 11592104
[TBL] [Abstract][Full Text] [Related]
29. Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor.
Shanmukhappa K; Sabla GE; Degen JL; Bezerra JA
BMC Gastroenterol; 2006 Nov; 6():40. PubMed ID: 17134505
[TBL] [Abstract][Full Text] [Related]
30. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
Bugge TH; Flick MJ; Danton MJ; Daugherty CC; Romer J; Dano K; Carmeliet P; Collen D; Degen JL
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5899-904. PubMed ID: 8650190
[TBL] [Abstract][Full Text] [Related]
31. Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung.
Hattori N; Sisson TH; Xu Y; Desai TJ; Simon RH
Am J Physiol; 1999 Sep; 277(3):L573-9. PubMed ID: 10484465
[TBL] [Abstract][Full Text] [Related]
32. Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice.
Piguet PF; Da Laperrousaz C; Vesin C; Tacchini-Cottier F; Senaldi G; Grau GE
Infect Immun; 2000 Jul; 68(7):3822-9. PubMed ID: 10858190
[TBL] [Abstract][Full Text] [Related]
33. Urokinase-type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms.
Uchida HA; Poduri A; Subramanian V; Cassis LA; Daugherty A
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2845-52. PubMed ID: 21868698
[TBL] [Abstract][Full Text] [Related]
34. In vivo fluorescence-mediated tomography for quantification of urokinase receptor-dependent leukocyte trafficking in inflammation.
Larmann J; Frenzel T; Hahnenkamp A; Herzog C; Lorenz A; Steinbicker AU; Calmer S; Harendza T; Schmitz M; Echtermeyer F; Hildebrand R; Bremer C; Theilmeier G
Anesthesiology; 2010 Sep; 113(3):610-8. PubMed ID: 20693875
[TBL] [Abstract][Full Text] [Related]
35. Lack of P-selectin glycoprotein ligand-1 protects mice from thrombosis after collagen/epinephrine challenge.
Miszti-Blasius K; Debreceni IB; Felszeghy S; Dezso B; Kappelmayer J
Thromb Res; 2011 Mar; 127(3):228-34. PubMed ID: 21237501
[TBL] [Abstract][Full Text] [Related]
36. Urokinase-type plasminogen activator deficiency has little effect on seizure susceptibility and acquired epilepsy phenotype but reduces spontaneous exploration in mice.
Rantala J; Kemppainen S; Ndode-Ekane XE; Lahtinen L; Bolkvadze T; Gurevicius K; Tanila H; Pitkänen A
Epilepsy Behav; 2015 Jan; 42():117-28. PubMed ID: 25506794
[TBL] [Abstract][Full Text] [Related]
37. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.
Falati S; Liu Q; Gross P; Merrill-Skoloff G; Chou J; Vandendries E; Celi A; Croce K; Furie BC; Furie B
J Exp Med; 2003 Jun; 197(11):1585-98. PubMed ID: 12782720
[TBL] [Abstract][Full Text] [Related]
38. Urokinase-type plasminogen activator promotes paracellular transmigration of neutrophils via Mac-1, but independently of urokinase-type plasminogen activator receptor.
Reichel CA; Uhl B; Lerchenberger M; Puhr-Westerheide D; Rehberg M; Liebl J; Khandoga A; Schmalix W; Zahler S; Deindl E; Lorenzl S; Declerck PJ; Kanse S; Krombach F
Circulation; 2011 Oct; 124(17):1848-59. PubMed ID: 21969013
[TBL] [Abstract][Full Text] [Related]
39. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways.
Idell S
Crit Care Med; 2002 May; 30(5 Suppl):S274-80. PubMed ID: 12004248
[TBL] [Abstract][Full Text] [Related]
40. The urokinase/urokinase receptor system mediates the IgG immune complex-induced inflammation in lung.
Shushakova N; Eden G; Dangers M; Menne J; Gueler F; Luft FC; Haller H; Dumler I
J Immunol; 2005 Sep; 175(6):4060-8. PubMed ID: 16148155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
